The India fusidic acid market is experiencing steady growth, driven by the rising incidence of bacterial infections, particularly skin and soft tissue infections, and the increasing prevalence of antibiotic-resistant strains such as MRSA. The dermatology and hospital settings use fusidic acid as a targeted antibiotic which effectively treats Gram-positive bacterial infections. The drug maintains constant demand because it treats both outpatient and inpatient medical needs.